Blog

ImmuPharma (LSE:IMM) has reported progress in strengthening the intellectual property and scientific foundation of its P140 autoimmune technology platform. The company recently received a supportive first Combined Search and Examination Report for a UK patent application submitted in September 2025. As the next step, management plans to file under the Patent Cooperation Treaty to extend patent protection across major commercial markets, highlighting the strategic importance of P140 within its development pipeline.

Further supporting the programme, a new study designed to stress test the associated diagnostic and reinforce statistical reliability delivered positive results that strengthen the patent position. In parallel, the company is preparing a scientific manuscript explaining the mechanism of action of P140 for submission to a peer-reviewed journal. ImmuPharma also continues to engage with potential partners, including meetings at the Bio Europe Spring conference, as it works toward securing a licensing agreement for P140 in 2026. Such a deal could play a significant role in shaping the company’s future revenue prospects and strategic positioning within the sector.

From an outlook perspective, the company remains constrained by weak financial fundamentals, including minimal revenue, ongoing losses, continued cash burn and negative equity. Technical indicators present a mixed picture but show some modest support relative to the 200-day average. Valuation metrics remain challenging due to the lack of profitability and the absence of a dividend.

More about ImmuPharma PLC

ImmuPharma PLC is a UK-listed specialty biopharmaceutical company focused on the discovery and development of peptide-based therapies. Its research programmes target autoimmune conditions and anti-infective indications, positioning the company within a specialised segment of the biopharmaceutical industry focused on precision treatments for immune-related diseases.

Avacta Group plc (LSE:AVCT) has announced plans to raise approximately £10 million through a discounted equity placing and subscription involving around 15.9 million new shares priced at 63 pence each. Zeus Capital is acting as sole bookrunner for the transaction. The company expects the net proceeds to fund research and development activities as well as general working capital, extending its cash runway into early Q1 2027 and beyond the anticipated Phase 1a data readout for AVA6103.

The capital raise is intended to support continued clinical progress across Avacta’s oncology pipeline. This includes Phase 1b expansion cohorts for faridoxorubicin (AVA6000) across multiple cancer indications and the planned initiation of dosing for AVA6103, a pre|CISION-based exatecan peptide drug conjugate. Management has indicated it intends to retain full ownership of AVA6103 at least until the initial Phase 1a data expected in late 2026. Participation by company directors in the subscription is seen as a signal of internal confidence and positions the group for potential future partnership discussions around its lead assets and next-generation candidate AVA6207.

From an outlook perspective, Avacta continues to face financial pressures, reflected in weak profitability and bearish technical indicators. Although the company is making progress with its clinical programmes, funding constraints and the absence of major commercial partnerships remain key risks. Valuation metrics also appear challenging given negative earnings and the lack of a dividend.

More about Avacta Group plc

Avacta Group plc is a clinical-stage biopharmaceutical and life sciences company developing cancer therapies using its proprietary pre|CISION tumour-activated drug delivery platform. The technology supports the development of peptide drug conjugates designed to deliver highly potent cancer treatments directly within the tumour microenvironment, aiming to improve effectiveness while reducing systemic toxicity compared with conventional antibody drug conjugates.

80 Mile Plc (LSE:80M) has announced that Pelican Acquisition Corporation has completed its acquisition of Greenland Exploration Limited, which has now started trading on Nasdaq as Greenland Energy Company under the ticker GLND. The listing consolidates the Jameson hydrocarbon project in East Greenland within a single U.S.-listed entity. Under the terms of an existing joint venture, GLND can earn up to a 70% interest in the project by funding the drilling of two exploration wells, leaving 80 Mile with a 30% stake. Based on Greenland Energy’s latest market capitalisation, that retained interest is valued at approximately US$104 million.

The Jameson project spans around two million acres in East Greenland and has undergone extensive technical evaluation. An independent report by Sproule ERCE estimates gross unrisked recoverable prospective oil resources of 13.03 billion barrels (P10), with roughly 3.9 billion barrels potentially attributable to 80 Mile following full earn-in by GLND. Preparations for drilling are advancing, with Halliburton contracted for drilling services, heavy equipment mobilised and logistical arrangements already in place. The Nasdaq listing of Greenland Energy is expected to provide a dedicated capital markets platform to fund and carry out a maiden drilling programme targeted for the second half of 2026, which could significantly reshape 80 Mile’s exposure to one of the world’s largest undeveloped onshore basins.

From an outlook perspective, the company’s financial profile remains challenged by the absence of revenue, widening losses and ongoing cash burn, which increases the risk of future funding needs and potential dilution despite relatively low debt levels. Technical indicators show strong upward momentum and a supportive longer-term trend, although overbought signals suggest some caution in the near term. Valuation remains difficult to assess given negative earnings and the lack of dividend data.

More about 80 Mile Plc

80 Mile Plc is an exploration and development company listed on AIM in London, the Frankfurt Stock Exchange and the U.S. OTC market. The group focuses on hydrocarbon and high-grade critical metal projects in Greenland, while also operating an industrial gas and biofuels business in Italy. This diversified portfolio provides exposure across hydrocarbons, base and precious metals, as well as sustainable fuel markets.

Chariot (LSE:CHAR) has arranged financing that will give it economic exposure to producing offshore oil assets in Angola by supporting Etu Energias’ acquisition of stakes in Blocks 14 and 14K. The company has provided a US$12 million deposit and related transaction costs to help fund Etu’s purchase of a 20% working interest in Block 14 and a 10% stake in Block 14K. The transaction is also supported by an acquisition financing facility from Shell Western Supply and Trading, which will be repaid through future oil offtake.

The funding package fully supports the acquisition and positions Chariot to benefit from long-term production-linked cash flows equivalent to roughly 4,000 barrels of oil per day. At an assumed oil price of US$60 per barrel, the arrangement is estimated to represent a net asset value exceeding US$100 million. The deal represents a strategic step for Chariot as it moves into material production within Angola’s established offshore basin, leveraging existing infrastructure operated by Chevron. Completion of the transaction is expected in the second half of 2026, subject to regulatory approvals.

From an outlook perspective, the company continues to face financial pressures, including ongoing losses and bearish technical indicators. However, strategic developments such as partnerships and the company’s expanding focus on renewable energy projects may provide potential for longer-term improvement. Valuation remains constrained by the company’s current lack of profitability.

More about Chariot Limited

Chariot Limited is an Africa-focused energy group with two main business areas: upstream oil and gas and renewable power development. Its oil and gas portfolio spans Angola, Morocco and Namibia, while its renewable energy division focuses on power generation and trading in South Africa as well as advancing power-to-mining and green hydrogen projects, including Project Nour in Mauritania.

GB Group plc (LSE:GBG), the London-listed identity technology specialist, has completed a refinancing of its revolving credit facility, arranging a new unsecured £175 million facility that extends the maturity to September 2030. The new agreement replaces the company’s previous secured facility, which had been due to expire in July 2027, providing the group with a longer-term funding structure.

The refinancing was arranged with a syndicate of existing and new banking partners, including HSBC Innovation Bank, NatWest, Barclays and Fifth Third Bank. While the commercial terms remain broadly similar to the previous arrangement, the extended tenor and additional extension options are expected to improve the group’s capital flexibility and strengthen its balance sheet ahead of its upcoming full-year trading update.

GB Group operates a global platform providing identity verification and fraud prevention services designed to support secure digital transactions and protect businesses from fraud. With more than 1,000 employees, the company delivers data-driven identity solutions to a wide international client base and plays a key role in enabling trust within digital ecosystems.

From an outlook perspective, GB Group benefits from strong financial performance and ongoing strategic initiatives, including share buybacks and improvements to its market listing profile, which support shareholder value. However, relatively high valuation metrics and mixed technical indicators suggest a degree of caution. While operational improvements and strategic developments provide positive momentum, elevated price-to-earnings levels and challenges in certain business segments temper the overall outlook.

More about GB Group plc

GB Group plc is a global identity technology company that enables individuals to securely verify their identity and address across digital channels. The FTSE 250-listed business provides mission-critical identity verification and fraud prevention services to more than 20,000 organisations worldwide, helping businesses combat digital crime, meet regulatory requirements and support secure growth across multiple industries.

Senior plc (LSE:SNR) has confirmed that private equity firm Advent International remains in discussions with the company regarding a potential takeover, after its earlier non-binding all-cash proposal of up to 272 pence per share was rejected. As negotiations continue, the deadline under UK takeover regulations for Advent to either announce a firm offer or withdraw has been pushed back from 27 March to 17 April 2026. The timetable could be extended further if regulators grant additional approval.

The company also revealed it is holding talks with other prospective bidders, signalling broader strategic interest in the business despite the absence of any agreed transaction. With the offer period now extended, Senior remains an active takeover candidate in the market, leaving investors and employees awaiting greater clarity on possible ownership changes and the company’s long-term strategic direction.

From an outlook perspective, Senior’s financial performance has been steady, supported by a recent earnings update highlighting improving margins, strong cash conversion and ongoing deleveraging. Technical indicators appear supportive but somewhat stretched following recent gains. Valuation remains the primary constraint on the investment case, with the shares trading on a relatively high price-to-earnings multiple and offering a modest dividend yield.

More about Senior plc

Senior plc is a UK-listed engineering group that designs and manufactures high-technology components and systems for aerospace, defence and industrial markets. The company focuses on supplying performance-critical products to original equipment manufacturers and other major customers across global transportation and industrial sectors.

Hargreaves Services (LSE:HSP) has announced plans to return up to £20 million to shareholders through a tender offer to repurchase as many as 2,352,941 ordinary shares, equivalent to roughly 7.12% of its anticipated issued share capital. The company is offering 850 pence per share, representing a premium of about 16.4% to the most recent closing price and approximately 26.9% above the share price prior to the initial announcement of the buyback proposal.

Under the terms of the offer, shareholders will be able to tender up to around 7.12% of their holdings as a basic entitlement. Participants may also apply to sell additional shares if other investors choose not to take up their full allocation. Several major stakeholders, including company directors and the largest shareholder, Harwood Capital, have indicated they will tender at least their basic entitlements. The transaction will be carried out through broker Singer Capital Markets and remains subject to shareholder approval at a general meeting scheduled for 29 April.

If completed, the tender is expected to modestly reduce the company’s free float while providing support to the share price. Most of the shares repurchased are expected to be cancelled, which could slightly increase the proportional holdings of directors and other shareholders who do not participate in the offer.

From an outlook perspective, Hargreaves benefits from solid financial performance, supported by strong revenue growth, healthy cash generation and low leverage. Technical indicators also point to positive momentum, with the share price trading above key moving averages and a favourable MACD trend. Valuation metrics remain attractive, highlighted by a relatively low price-to-earnings ratio and a strong dividend yield. However, execution risks remain around certain projects, including developments in land and renewable energy and progress on the group’s zinc project.

More about Hargreaves Services PLC

Hargreaves Services PLC is a diversified UK-based group operating across environmental, infrastructure and property sectors. The company provides industrial and land development services and focuses on disciplined capital allocation while delivering returns to shareholders within its chosen markets.

Conduit Holdings Limited (LSE:CRE), the London-listed parent company of Bermuda-based reinsurer Conduit Re, has appointed Richard Lightowler, Peter Mullen and Penny Shaw as non-executive directors, with the appointments taking effect on 26 March 2026. The new board members will also serve on the company’s audit and remuneration committees. Their combined expertise across insurance, risk management, capital markets and corporate governance is expected to strengthen oversight as the group continues to expand its global reinsurance operations.

Chair Nicholas Shott said the appointments bring significant industry experience and strategic insight to the board at an important stage in the company’s development. As Conduit continues to build on recent progress, the enhanced board structure is intended to support sound governance and reinforce the company’s focus on delivering sustainable long-term value to shareholders. The additions also better align the board with the growing complexity of global reinsurance and alternative risk markets, which could further strengthen investor confidence in the business.

Conduit operates a diversified reinsurance platform with global reach through its Bermuda-based subsidiary, supported by a Class 4 insurance licence from the Bermuda Monetary Authority and A- (Excellent) ratings from A.M. Best. The group leverages its Bermuda base and London listing to maintain capital strength while pursuing international growth opportunities.

From an outlook perspective, Conduit’s investment profile benefits from strong financial quality, including low leverage and expanding equity, as well as solid earnings and cash generation. Technical indicators also suggest positive momentum. However, valuation remains a potential constraint, with a relatively high price-to-earnings ratio despite an attractive dividend yield, alongside a step-down in profitability following 2023.

More about Conduit Holdings Limited

Conduit Holdings Limited is the ultimate parent company of Conduit Re, a Bermuda-based multi-line reinsurance business with a global underwriting footprint. Listed on the London Stock Exchange under the ticker CRE, the group provides reinsurance across a range of lines through Conduit Reinsurance Limited, which is licensed as a Class 4 insurer by the Bermuda Monetary Authority and holds an A- (Excellent) financial strength rating and a- (Excellent) long-term issuer credit rating from A.M. Best, both with a stable outlook.